• Molecular NamePralidoxime
  • SynonymPralidoxime Chloride
  • Weight137.162
  • Drugbank_IDDB00733
  • ACS_NO6735-59-7
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)1.1
  • pka8.0
  • LogD (pH=7, predicted)-1.88
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.02
  • LogSw (predicted, AB/LogsW2.0)1.89
  • Sw (mg/ml) (predicted, ACD/Labs)13.18
  • No.of HBond Donors1
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds1
  • TPSA34.28
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyIt is used to combat poisoning by organophosphates or acetylcholinesterase inhibitors (nerve agents), in conjunction with atropine and diazepam.
  • Absorption_value30.0
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding0.0
  • Volume of distribution (VD)0.6 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life1 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A